Audiologists in Tripler Amc, HI Accepting Medicare
4 Audiologists found. Showing 1 - 4
 Ms. Amy Elizabeth Hines, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center Attn: Mchk-qs, Tripler Amc, HI 96859 Phone: 808-433-2460 Fax: 808-433-1558 |
Dr. Natalie Marie Feleppelle, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Amc, HI 96859 Phone: 888-683-2778 |
Dr. Jennifer Stidley, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Amc, HI 96859 Phone: 808-433-8326 |
Denby K F Rall, AU.D. CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, Tripler Amc, HI 96859 Phone: 808-433-5742 |
News Archive
Estrogen-alone hormone therapy had no effect on coronary heart disease risk
A large, multi-center heart disease prevention study, part of the Women's Health Initiative (WHI), found that estrogen-alone hormone therapy had no effect on coronary heart disease risk but increased the risk of stroke for postmenopausal women.
Clinical dietitian comments on documentary highlighting obesity epidemic
"The movie seeks to remove blame from the individual who is obese and overweight," says Lisa Cimperman, RD, clinical dietitian at University Hospitals Case Medical Center about "Fed Up," a documentary on the obesity epidemic currently in theaters. "The overriding theme is the food industry and sugar are responsible for driving the obesity epidemic."
Apogenix signs licensing agreement with CANbridge to commercialize APG101 in China, Macao and Hong Kong
Apogenix, a next generation immuno-oncology company, announced today that it has entered into an exclusive licensing agreement with CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, for the development and commercialization of lead immuno-oncology drug candidate APG101 in China, Macao, and Hong Kong.
Carbon-based nanomaterials as potential COVID-19 treatments
An international team of researchers says that carbon-based nanomaterials (CBNs) could represent promising new approaches to treating coronavirus disease 2019 (COVID-19) pneumonia that is complicated by a secondary bacterial, viral or fungal infection.
› Verified 2 days ago
Physical Therapists
Optometrists
Occupational Therapists
Audiologists
Speech-Language Pathologists
Chiropractors